Department of Internal Medicine and Metabolic Diseases, Medical University of Bialystok, Bialystok, Poland.
Department of Internal Medicine and Metabolic Diseases, Medical University of Bialystok, Bialystok, Poland.
Psychoneuroendocrinology. 2023 Dec;158:106409. doi: 10.1016/j.psyneuen.2023.106409. Epub 2023 Sep 30.
The relationship between brain natriuretic peptides and depression was studied in patients with cardiovascular diseases (CVD), but the data in people without CVD are limited. Metabolic disturbances can be associated with natriuretic peptides' levels. The study aimed to assess serum N-terminal pro-brain natriuretic peptide (NT-proBNP) level in women with depressive symptoms and its relationship with metabolic disturbances.
The analysis included 347 women (20-60 years old) from Bialystok PLUS cohort study: 98 with depressive symptoms and 249 controls. Clinical examination, oral glucose tolerance test (OGTT) and assessment of lipid, sex hormone binding globulin (SHBG) and NT-proBNP concentrations in the blood were performed. The participants completed Beck Depression Inventory questionnaire.
Metabolic syndrome was more frequent in the group of women with depressive symptoms compared to women without depressive symptoms. Women with depressive symptoms had lower NT-proBNP level than the control group - 45.88 (27.80-67.04) vs 56.49 (32.42-94.25) pg/mL, p = 0.027. Multiple linear regression analysis of all women showed that NT-proBNP level was reversely associated with the presence of depressive symptoms, waist circumference and heart rate and positively connected with age. In the group of women with depressive symptoms, we observed negative correlations between NT-proBNP level and insulin concentration at 60 min of OGTT, diastolic blood pressure and a positive correlation with SHBG.
NT-proBNP level is decreased in women with depressive symptoms, which might be connected with metabolic disturbances in this group.
在患有心血管疾病 (CVD) 的患者中研究了脑利钠肽与抑郁之间的关系,但在没有 CVD 的人群中的数据有限。代谢紊乱可能与利钠肽水平相关。本研究旨在评估有抑郁症状的女性血清 N 末端脑利钠肽前体 (NT-proBNP) 水平及其与代谢紊乱的关系。
该分析包括来自比亚韦斯托克 PLUS 队列研究的 347 名女性(20-60 岁):98 名有抑郁症状,249 名对照组。进行了临床检查、口服葡萄糖耐量试验 (OGTT) 和血液中脂质、性激素结合球蛋白 (SHBG) 和 NT-proBNP 浓度的评估。参与者完成贝克抑郁量表问卷。
与无抑郁症状的女性相比,有抑郁症状的女性代谢综合征更为常见。有抑郁症状的女性 NT-proBNP 水平低于对照组 - 45.88(27.80-67.04)vs 56.49(32.42-94.25)pg/mL,p=0.027。所有女性的多元线性回归分析表明,NT-proBNP 水平与抑郁症状的存在、腰围和心率呈负相关,与年龄呈正相关。在有抑郁症状的女性中,我们观察到 NT-proBNP 水平与 OGTT 60 分钟时的胰岛素浓度、舒张压呈负相关,与 SHBG 呈正相关。
有抑郁症状的女性 NT-proBNP 水平降低,这可能与该组的代谢紊乱有关。